Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1984-06-29
1987-01-27
Hazel, Blondel
Drug, bio-affecting and body treating compositions
Lymphokine
530403, 514 2, A61K 39012, A61K 3700
Patent
active
046393722
ABSTRACT:
Sporozoites of coccidia fail to develop in chickens which are immune and many are blocked from penetrating host cells. Although previous attempts to immunize chickens with non-viable coccidial antigens have been unsuccessful it has been discovered that extracts from sporozoites or sporulated oocysts of E. tennella induce high levels of protective immunity. These extracts contain at least 15 polypeptides many of which are associated with the surface of the sporozoite and induce good immune responses. Antibody to these polypeptides blocks sporozoite-host cell penetration in vitro and neutralizes sporozoites in vivo. One or more of these polypeptides may be used as an antigen to protect against coccidiosis.
REFERENCES:
Statish, R. et al., J. Biol. Chem., vol. 251, pp. 302-307.
Rose et al., Symposium of the British Society for Porasitology, vol. 18, pp. 57-74, 1980.
Galuska Stefan
Murray Peter K.
Hazel Blondel
Merck & Co. , Inc.
Perrella Donald J.
Pfeiffer Hesna J.
LandOfFree
Coccidiosis vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Coccidiosis vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Coccidiosis vaccine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-857478